Skip to main content

. 1995 Jul;74(1):13. doi: 10.1136/hrt.74.1.13

Statins: is there a need for alternative or adjunctive therapy?

PMCID: PMC483938 PMID: 7662445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Feher M. D., Foxton J., Banks D., Lant A. F., Wray R. Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease. Br Heart J. 1995 Jul;74(1):14–17. doi: 10.1136/hrt.74.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
Feussner G. HMG CoA reductase inhibitors. Curr Opin Lipidol. 1994 Feb;5(1):59–68. doi: 10.1097/00041433-199402000-00010. [DOI] [PubMed] [Google Scholar]
Grundy S. M. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med. 1988 Jul 7;319(1):24–33. doi: 10.1056/NEJM198807073190105. [DOI] [PubMed] [Google Scholar]
Shepherd J. Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety. Eur Heart J. 1995 Jan;16(1):5–13. doi: 10.1093/eurheartj/16.1.5. [DOI] [PubMed] [Google Scholar]
Shepherd J. Mechanism of action of fibrates. Postgrad Med J. 1993;69 (Suppl 1):S34–S41. [PubMed] [Google Scholar]

ACTIONS

RESOURCES